The present invention encompasses the surprising finding that romidepsin can safely be administered to humans on an accelerated dosing schedule.

 
Web www.patentalert.com

< SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA

< BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES

> METHODS AND COMBINATION THERAPIES FOR TREATING ALZHEIMER'S DISEASE

> QUINOLINE DERIVATIVES AS P13 KINASE INHIBITORS
~ 00616